188 related articles for article (PubMed ID: 20173780)
21. Caspases and receptor cleavage.
Graf D; Bode JG; Häussinger D
Arch Biochem Biophys; 2007 Jun; 462(2):162-70. PubMed ID: 17482137
[TBL] [Abstract][Full Text] [Related]
22. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
23. Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration.
Sewell JM; Smyth JF; Langdon SP
Exp Cell Res; 2005 Mar; 304(1):305-16. PubMed ID: 15707595
[TBL] [Abstract][Full Text] [Related]
24. Dual role of TMS1/ASC in death receptor signaling.
Parsons MJ; Vertino PM
Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
[TBL] [Abstract][Full Text] [Related]
25. TRAIL and apoptosis induction by TNF-family death receptors.
Wang S; El-Deiry WS
Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
27. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis.
Eastman A
Semin Cancer Biol; 1995 Feb; 6(1):45-52. PubMed ID: 7548841
[TBL] [Abstract][Full Text] [Related]
28. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
29. TRAIL signalling: decisions between life and death.
Falschlehner C; Emmerich CH; Gerlach B; Walczak H
Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612
[TBL] [Abstract][Full Text] [Related]
30. The dependence receptor hypothesis.
Mehlen P; Bredesen DE
Apoptosis; 2004 Jan; 9(1):37-49. PubMed ID: 14739597
[TBL] [Abstract][Full Text] [Related]
31. [Cell survival: differences and differentiation].
Vachon PH
Med Sci (Paris); 2006 Apr; 22(4):423-9. PubMed ID: 16597413
[TBL] [Abstract][Full Text] [Related]
32. Cell death and survival signaling in oncogenesis.
Fulda S
Klin Padiatr; 2010 Nov; 222(6):340-4. PubMed ID: 20862627
[TBL] [Abstract][Full Text] [Related]
33. Dependence receptors and colorectal cancer.
Mehlen P; Tauszig-Delamasure S
Gut; 2014 Nov; 63(11):1821-9. PubMed ID: 25163468
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction pathways participating in homeostasis and malignant transformation of the intestinal tissue.
Krausova M; Korinek V
Neoplasma; 2012; 59(6):708-18. PubMed ID: 22862172
[TBL] [Abstract][Full Text] [Related]
35. Dependence Receptors and Cancer: Addiction to Trophic Ligands.
Gibert B; Mehlen P
Cancer Res; 2015 Dec; 75(24):5171-5. PubMed ID: 26627011
[TBL] [Abstract][Full Text] [Related]
36. [Dependence receptors: links between apoptosis, nervous system development and control of tumorigenesis].
Mehlen P; Bredesen DE
Bull Cancer; 2000 Jul; 87(7-8):537-41. PubMed ID: 10969210
[TBL] [Abstract][Full Text] [Related]
37. Dependence receptors - the dark side awakens.
Negulescu AM; Mehlen P
FEBS J; 2018 Nov; 285(21):3909-3924. PubMed ID: 29776009
[TBL] [Abstract][Full Text] [Related]
38. Dependence receptors: the trophic theory revisited.
Mehlen P
Sci Signal; 2010 Dec; 3(151):pe47. PubMed ID: 21139137
[TBL] [Abstract][Full Text] [Related]
39. Dependence receptors: new targets for cancer therapy.
Brisset M; Grandin M; Bernet A; Mehlen P; Hollande F
EMBO Mol Med; 2021 Nov; 13(11):e14495. PubMed ID: 34542930
[TBL] [Abstract][Full Text] [Related]
40. [Cell signalling and cancer].
Robert J
Bull Cancer; 2010 Nov; 97(11):1215-22. PubMed ID: 21047720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
